Pfizer to Merge Off-Patent Drug Business With Mylan: WSJ

In this article:

Pfizer plans to divest its off-patent drug business and combine it with Mylan. The newly formed company will put Mylan's EpiPen and Pfizer's Viagra under one umbrella. Yahoo Finance's Akiko Fujita and Scott Gamm discuss.

Advertisement